ERBB2 and inflammatory breast carcinoma: The 5 general molecular subtypes of nIBC (luminal A, luminal B, basal-like, HER2-enriched, and normal-like) are also represented in IBC, and IBC patients have a poorer prognosis regardless of the subtype5, 6, 10, 13, 14.